3
Total investments
0
Early stage
2
Mid stage
0
Late stage
2y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Apr 2026
Sequential advances personal care and health research by studying the real-world impact of products through human clinical testing, biomarker discovery, and next-generation formulations across skin, scalp, oral, and vaginal care. Our end-to-end, in-house platform, from study design and participant recruitment (tailored to any required criteria) to laboratory analysis and data interpretation, turns complex biological data into clear, actionable insights. By combining microbial and molecular analyses, we enable the development of credible, effective, and trustworthy products and claims. With a database of over 50,000 samples, 4,000+ ingredients, and 10,000+ participants worldwide, Sequential leverages years of scientific expertise to set the standard for data-driven innovation and product validation in the personal care and pharmaceutical industries.
Board Observer
Oct 2024
microTERRA is pioneering sustainable food ingredients by harnessing the cleansing power of Lemna. This remarkable aquatic plant has the unique ability to clean water while simultaneously producing valuable functional ingredients such as Flora: The Taste & Feel Ingredient. Flora increases sweetness perception while reducing sugar in formulations. It also helps mask unwanted notes from high-intensity sweeteners. This represents a market opportunity in a $40Bn industry. Flora is the first of many ingredients to come, as microTERRA is an ingredient platform that develops specialty ingredients sustainably.
Experience · 7 entries
All (7)
Investments (3)
Board (3)
2026
Board Observer
Apr 2026
Sequential advances personal care and health research by studying the real-world impact of products through human clinical testing, biomarker discovery, and next-generation formulations across skin, scalp, oral, and vaginal care. Our end-to-end, in-house platform, from study design and participant recruitment (tailored to any required criteria) to laboratory analysis and data interpretation, turns complex biological data into clear, actionable insights. By combining microbial and molecular analyses, we enable the development of credible, effective, and trustworthy products and claims. With a database of over 50,000 samples, 4,000+ ingredients, and 10,000+ participants worldwide, Sequential leverages years of scientific expertise to set the standard for data-driven innovation and product validation in the personal care and pharmaceutical industries.
2024
Board Observer
Oct 2024
microTERRA is pioneering sustainable food ingredients by harnessing the cleansing power of Lemna. This remarkable aquatic plant has the unique ability to clean water while simultaneously producing valuable functional ingredients such as Flora: The Taste & Feel Ingredient. Flora increases sweetness perception while reducing sugar in formulations. It also helps mask unwanted notes from high-intensity sweeteners. This represents a market opportunity in a $40Bn industry. Flora is the first of many ingredients to come, as microTERRA is an ingredient platform that develops specialty ingredients sustainably.
Board Observer
Sep 2024
We are a biotech company developing microbiome-based female health products created for women by a female led team of scientists. Our patent-pending, science-backed technology is now available at p-happi.com.
2023
Partnerships & Corporate Investor Relations Manager | IndieBio NY
Feb 2023
SOSV is the most active deep tech venture capital firm globally, investing at pre-seed (or at startup inception) supporting visionary founders intent on making a profound impact on human and planetary health.
SOSV has three deeply resourced locations for founders in San Francisco (SOSV SF), New York (SOSV NY), and Newark (SOSV HAX). Each year, SOSV makes roughly 60 pre-seed investments of up to $550K each, as well as another 150 follow-on investments in deep tech companies. The pre-seed founders spend 4–6 months working side-by-side with SOSV General Partners and the broader team of experts in science and engineering, design and product development, supply chain and product-market fit. Additionally, founders gain access to each location’s office space and equipped lab space.
2020
Associate Consultant - Commercial Practice
Mar 2020
At IBM, we do more than work. We create. We create as technologists, developers, and engineers. We create with our partners. We create with our competitors. If youre searching for ways to make the world work better through technology and infrastructure, software and consulting, then we want to work with you.
Were here to help every creator turn their "what if" into what is. Lets create something that will change everything.
Show all 7 entries ↓
Investment activity
2024–2026 · 3 investments
Recent (last 2 years)Earlier
